Multiple Dose ASM8 in Mild Asthmatics

Status:
Completed

Trial end date:
2006-04-01

Target enrollment:

Participant gender:

To determine the safety and efficacy of multiple doses of ASM8 antisense oligonucleotides in asthmatics.

Phase 1/Phase 2

Pharmaxis